Renaissance Technologies’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-271,200
| Closed | -$2.6M | – | 3975 |
|
|
2024
Q4 | $2.6M | Sell |
271,200
-626,403
| -70% | -$6.01M | ﹤0.01% | 1875 |
|
|
2024
Q3 | $2.57M | Buy |
897,603
+42,703
| +5% | +$122K | ﹤0.01% | 1859 |
|
|
2024
Q2 | $2.5M | Buy |
854,900
+297,500
| +53% | +$869K | ﹤0.01% | 1733 |
|
|
2024
Q1 | $1.78M | Buy |
557,400
+27,300
| +5% | +$87.1K | ﹤0.01% | 2107 |
|
|
2023
Q4 | $1.78M | Sell |
530,100
-252,971
| -32% | -$850K | ﹤0.01% | 2028 |
|
|
2023
Q3 | $1.86M | Buy |
783,071
+243,047
| +45% | +$579K | ﹤0.01% | 1912 |
|
|
2023
Q2 | $950K | Sell |
540,024
-63,176
| -10% | -$111K | ﹤0.01% | 2495 |
|
|
2023
Q1 | $1.86M | Buy |
603,200
+406,900
| +207% | +$1.25M | ﹤0.01% | 2076 |
|
|
2022
Q4 | $1.04M | Sell |
196,300
-147,000
| -43% | -$779K | ﹤0.01% | 2513 |
|
|
2022
Q3 | $1.21M | Sell |
343,300
-36,800
| -10% | -$130K | ﹤0.01% | 2377 |
|
|
2022
Q2 | $981K | Buy |
380,100
+193,100
| +103% | +$498K | ﹤0.01% | 2738 |
|
|
2022
Q1 | $838K | Buy |
187,000
+153,400
| +457% | +$687K | ﹤0.01% | 2848 |
|
|
2021
Q4 | $229K | Buy |
33,600
+20,700
| +160% | +$141K | ﹤0.01% | 3462 |
|
|
2021
Q3 | $94K | Buy |
+12,900
| New | +$94K | ﹤0.01% | 3327 |
|